A 2020 review published in the European Review for Medical and Pharmacological Sciences analysed 11 clinical trials involving hundreds of reflux patients to compare alginate against both placebo and acid-suppressing medication.
The findings were significant.
Across multiple trials, alginate consistently outperformed placebo and standard antacids in reducing heartburn, regurgitation and digestive discomfort.
But perhaps more telling was what happened when researchers compared alginate directly against PPIs.
Not because alginate underperformed — but because Alginates matched them.
A natural compound derived from seaweed, with no effect on acid production whatsoever, produced comparable outcomes to one of the most widely prescribed classes of medication in the world.
And it did so without the side effects.
The same research confirmed that the risk of adverse events with alginate was no greater than placebo.
The reason comes back to the mechanism - how it works.
While PPIs work by reducing how much acid your stomach produces, alginate works by targeting what researchers call the "acid pocket" — a reservoir of highly acidic fluid that sits in the upper stomach after eating, right at the point where acid enters the oesophagus.
Alginate forms a gel raft that physically displaces and covers that pocket, stopping acid from rising before it ever becomes a problem.
Two completely different approaches. Similar results. But only one of them is natural.